Series A - Vaxess Technologies

Series A - Vaxess Technologies

Investment Firm

Overview

Vaxess Technologies engages in developing biomedical innovations with a focus on improving access to vaccines.

Announced Date

May 23, 2013

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Norwich Ventures

Norwich Ventures

Norwich Ventures is a early_stage_venture and seed firm.

Participant Investors

1

Investor Name
Participant InvestorNorwich Ventures

Round Details and Background

Vaxess Technologies raised $3750000 on 2013-05-23 in Series A

Vaxess Technologies engages in developing biomedical innovations with a focus on improving access to vaccines.

Company Funding History

20

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Feb 03, 2015
Non Equity Assistance - Vaxess Technologies
1-1.0M
Jan 01, 2015
Grant - Vaxess Technologies
1-225.0K
Dec 01, 2013
Debt Financing - Vaxess Technologies
1-1.0M
May 23, 2013
Series A - Vaxess Technologies
1-3.8M

Recent Activity

There is no recent news or activity for this profile.